Amlodipine/Valsartan

DRUG5 trials

Sponsors

Yonsei University, TSH Biopharm Corporation Limited, Novartis Pharmaceuticals, Genuine Research Center, Egypt, International Bio service

Conditions

Essential HypertensionHealthyHealthy VolunteerHypertension

Phase 1

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

CompletedNCT02519010

Genuine Research Center, EgyptHealthy

Start: 2011-03-31End: 2011-03-31Updated: 2015-08-10

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

Not yet recruitingNCT06193044

International Bio serviceHealthy Volunteer

Start: 2024-05-07End: 2024-07-12Target: 48Updated: 2024-01-09

Phase 4

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

CompletedNCT01819220

Yonsei UniversityHypertension

Start: 2009-04-30End: 2014-11-30Updated: 2015-06-10

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

CompletedNCT02058446

TSH Biopharm Corporation LimitedEssential Hypertension

Start: 2013-10-31End: 2014-03-31Updated: 2015-11-13

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

CompletedNCT02062645

Novartis PharmaceuticalsEssential Hypertension

Start: 2014-02-28End: 2015-09-30Updated: 2017-03-28